Identification of GNA12‑driven gene signatures and key signaling networks in ovarian cancer
- Authors:
- Ji-Hee Ha
- Muralidharan Jayaraman
- Mingda Yan
- Padmaja Dhanasekaran
- Ciro Isidoro
- Yong-Sang Song
- Danny N. Dhanasekaran
-
Affiliations: Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma, OK 73104, USA, Laboratory of Molecular Pathology and NanoBioImaging, Department of Health Sciences, University of Eastern Piedmont, I‑17‑28100 Novara, Italy, Department of Obstetrics and Gynecology, Cancer Research Institute, College of Medicine, Seoul National University, Seoul 151‑921, Republic of Korea - Published online on: August 10, 2021 https://doi.org/10.3892/ol.2021.12980
- Article Number: 719
-
Copyright: © Ha et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer Statistics, 2021. CA Cancer J Clin. 71:7–33. 2021. View Article : Google Scholar : PubMed/NCBI | |
Bast RC Jr, Lu Z, Han CY, Lu KH, Anderson KS, Drescher CW and Skates SJ: Biomarkers and strategies for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 29:2504–2512. 2020. View Article : Google Scholar : PubMed/NCBI | |
Wang Q, Peng H, Qi X, Wu M and Zhao X: Targeted therapies in gynecological cancers: A comprehensive review of clinical evidence. Signal Transduct Target Ther. 5:1372020. View Article : Google Scholar : PubMed/NCBI | |
Mills GB and Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer. 3:582–591. 2003. View Article : Google Scholar : PubMed/NCBI | |
Cui R, Bai H, Cao G and Zhang Z: The role of lysophosphatidic acid receptors in ovarian cancer: A minireview. Crit Rev Eukaryot Gene Expr. 30:265–272. 2020. View Article : Google Scholar : PubMed/NCBI | |
Moolenaar WH: LPA: A novel lipid mediator with diverse biological actions. Trends Cell Biol. 4:213–219. 1994. View Article : Google Scholar : PubMed/NCBI | |
Moolenaar WH, van Meeteren LA and Giepmans BN: The ins and outs of lysophosphatidic acid signaling. Bioessays. 26:870–881. 2004. View Article : Google Scholar : PubMed/NCBI | |
Noguchi K, Herr D, Mutoh T and Chun J: Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol. 9:15–23. 2009. View Article : Google Scholar : PubMed/NCBI | |
Radhika V and Dhanasekaran N: Transforming G proteins. Oncogene. 20:1607–1614. 2001. View Article : Google Scholar : PubMed/NCBI | |
Goldsmith ZG and Dhanasekaran DN: G protein regulation of MAPK networks. Oncogene. 26:3122–3142. 2007. View Article : Google Scholar : PubMed/NCBI | |
Radhakrishnan R, Ha JH and Dhanasekaran DN: Mitogenic signaling by the gep oncogene involves the upregulation of S-phase kinase-associated protein 2. Genes Cancer. 1:1033–1043. 2010. View Article : Google Scholar : PubMed/NCBI | |
Ha JH, Radhakrishnan R, Jayaraman M, Yan M, Ward JD, Fung KM, Moxley K, Sood AK, Isidoro C, Mukherjee P, et al: LPA induces metabolic reprogramming in ovarian cancer via a pseudohypoxic response. Cancer Res. 78:1923–1934. 2018. View Article : Google Scholar : PubMed/NCBI | |
Radhakrishnan R, Ha JH, Jayaraman M, Liu J, Moxley KM, Isidoro C, Sood AK, Song YS and Dhanasekaran DN: Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 442:464–474. 2019. View Article : Google Scholar : PubMed/NCBI | |
Goldsmith ZG, Ha JH, Jayaraman M and Dhanasekaran DN: Lysophosphatidic acid stimulates the proliferation of ovarian cancer cells via the gep proto-oncogene Galpha(12). Genes Cancer. 2:563–575. 2011. View Article : Google Scholar : PubMed/NCBI | |
Ha JH, Gomathinayagam R, Yan M, Jayaraman M, Ramesh R and Dhanasekaran DN: Determinant role for the gep oncogenes, Galpha12/13, in ovarian cancer cell proliferation and xenograft tumor growth. Genes Cancer. 6:356–364. 2015. View Article : Google Scholar : PubMed/NCBI | |
Juneja J and Casey PJ: Role of G12 proteins in oncogenesis and metastasis. Br J Pharmacol. 158:32–40. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y and Casey PJ: A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J Biol Chem. 281:26483–24490. 2006. View Article : Google Scholar : PubMed/NCBI | |
Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, Daaka Y, Dewhirst MW, Fields TA and Casey PJ: The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci USA. 103:8173–8178. 2006. View Article : Google Scholar : PubMed/NCBI | |
Liu SC, Jen YM, Jiang SS, Chang JL, Hsiung CA, Wang CH and Juang JL: G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization. Cancer Res. 69:6122–6130. 2009. View Article : Google Scholar : PubMed/NCBI | |
Wuchty S, Zhang A, Walling J, Ahn S, Li A, Quezado M, Oberholtzer C, Zenklusen JC and Fine HA: Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biology. J Biomed Inform. 43:945–952. 2010. View Article : Google Scholar : PubMed/NCBI | |
Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA: DAVID Bioinformatics Resources: Expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 35:W169–W175. 2007. View Article : Google Scholar : PubMed/NCBI | |
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al: STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019. View Article : Google Scholar : PubMed/NCBI | |
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI | |
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and Lin CY: cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI | |
Liu Z, Meng J, Li X, Zhu F, Liu T, Wu G and Zhang L: Identification of hub genes and key pathways associated with two subtypes of diffuse large B-cell lymphoma based on gene expression profiling via integrated bioinformatics. Biomed Res Int. 2018:35745342018.PubMed/NCBI | |
Vogler O, Barcelo JM, Ribas C and Escriba PV: Membrane interactions of G proteins and other related proteins. Biochim Biophys Acta. 1778:1640–10652. 2008. View Article : Google Scholar : PubMed/NCBI | |
Solary E, Eymin B, Droin N and Haugg M: Proteases, proteolysis, and apoptosis. Cell Biol Toxicol. 14:121–132. 1998. View Article : Google Scholar : PubMed/NCBI | |
Yu H, Kim PM, Sprecher E, Trifonov V and Gerstein M: The importance of bottlenecks in protein networks: Correlation with gene essentiality and expression dynamics. PLoS Comput Biol. 3:e592007. View Article : Google Scholar : PubMed/NCBI | |
Charitou T, Bryan K and Lynn DJ: Using biological networks to integrate, visualize and analyze genomics data. Genet Sel Evol. 48:272016. View Article : Google Scholar : PubMed/NCBI | |
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al: The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2:401–404. 2012. View Article : Google Scholar : PubMed/NCBI | |
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI | |
Despierre E, Lambrechts D, Neven P, Amant F, Lambrechts S and Vergote I: The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment. Gynecol Oncol. 117:358–365. 2010. View Article : Google Scholar : PubMed/NCBI | |
Guan J, Darb-Esfahani S, Richter R, Taube ET, Ruscito I, Mahner S, Woelber L, Prieske K, Concin N, Vergote I, et al: Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): A study from the Tumor Bank Ovarian Cancer (TOC) Consortium. J Cancer Res Clin Oncol. 145:1063–1073. 2019. View Article : Google Scholar : PubMed/NCBI | |
Sopo M, Anttila M, Hamalainen K, Kivela A, Yla-Herttuala S, Kosma VM, Keski-Nisula L and Sallinen H: Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer. BMC Cancer. 19:5842019. View Article : Google Scholar : PubMed/NCBI | |
Li X, Hu Z, Shi H, Wang C, Lei J and Cheng Y: Inhibition of VEGFA increases the sensitivity of ovarian cancer cells to chemotherapy by suppressing VEGFA-Mediated Autophagy. Onco Targets Ther. 13:8161–8171. 2020. View Article : Google Scholar : PubMed/NCBI | |
Bai Y, Li LD, Li J, Chen RF, Yu HL, Sun HF, Wang JY and Lu X: A FXYD5/TGFβ/SMAD positive feedback loop drives epithelialtomesenchymal transition and promotes tumor growth and metastasis in ovarian cancer. Int J Oncol. 56:301–314. 2020.PubMed/NCBI | |
Liang S, Yao Q, Wei D, Liu M, Geng F, Wang Q and Wang YS: KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor-β1 expression. J Cell Biochem. 120:493–506. 2019. View Article : Google Scholar : PubMed/NCBI | |
Beale PJ, Rogers P, Boxall F, Sharp SY and Kelland LR: BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma. Br J Cancer. 82:436–440. 2000. View Article : Google Scholar : PubMed/NCBI | |
Yuan J, Lan H, Jiang X, Zeng D and Xiao S: Bcl2 family: Novel insight into individualized therapy for ovarian cancer (Review). Int J Mol Med. 46:1255–1265. 2020.PubMed/NCBI | |
Liang R, Chen X, Chen L, Wan F, Chen K, Sun Y and Zhu X: STAT3 signaling in ovarian cancer: A potential therapeutic target. J Cancer. 11:837–848. 2020. View Article : Google Scholar : PubMed/NCBI | |
Diener A and Rohrmann S: Associations of serum carotenoid concentrations and fruit or vegetable consumption with serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 concentrations in the Third National Health and Nutrition Examination survey (NHANES III). J Nutr Sci. 5:e132016. View Article : Google Scholar : PubMed/NCBI | |
Yahya MA, Sharon SM, Hantisteanu S, Hallak M and Bruchim I: The role of the insulin-like growth factor 1 pathway in immune tumor microenvironment and its clinical ramifications in gynecologic malignancies. Front Endocrinol (Lausanne). 9:2972018. View Article : Google Scholar : PubMed/NCBI | |
Khorram O, Garthwaite M, Grosen E and Golos T: Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril. 75:174–179. 2001. View Article : Google Scholar : PubMed/NCBI | |
Klukovits A, Schally AV, Szalontay L, Vidaurre I, Papadia A, Zarandi M, Varga JL, Block NL and Halmos G: Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers. Cancer. 118:670–680. 2012. View Article : Google Scholar : PubMed/NCBI | |
Wheaton K, Sarkari F, Stanly Johns B, Davarinejad H, Egorova O, Kaustov L, Raught B, Saridakis V and Sheng Y: UbE2E1/UBCH6 is a critical in vivo E2 for the PRC1-catalyzed ubiquitination of H2A at lys-119. J Biol Chem. 292:2893–2902. 2017. View Article : Google Scholar : PubMed/NCBI | |
Sohn D, Totzke G, Schulze-Osthoff K and Janicke RU: Friend or foe? The proteasome in combined cancer therapy. Cell Cycle. 5:841–845. 2006. View Article : Google Scholar : PubMed/NCBI | |
Sohn D, Totzke G, Essmann F, Schulze-Osthoff K, Levkau B and Janicke RU: The proteasome is required for rapid initiation of death receptor-induced apoptosis. Mol Cell Biol. 26:1967–1978. 2006. View Article : Google Scholar : PubMed/NCBI | |
Milone MR, Pucci B, Bifulco K, Iannelli F, Lombardi R, Ciardiello C, Bruzzese F, Carriero MV and Budillon A: Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype. Oncotarget. 6:5324–5341. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yim JH, Yun HS, Lee SJ, Baek JH, Lee CW, Song JY, Um HD, Park JK, Kim JS, Park IC and Hwang SG: Radiosensitizing effect of PSMC5, a 19S proteasome ATPase, in H460 lung cancer cells. Biochem Biophys Res Commun. 469:94–100. 2016. View Article : Google Scholar : PubMed/NCBI | |
Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova D, Tang Q, Feng B, Jiang L, He J, et al: Wild-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation. Cancer Cell. 35:191–203 e8. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ajeawung NF, Nguyen TTM, Lu L, Kucharski TJ, Rousseau J, Molidperee S, Atienza J, Gamache I, Jin W, Plon SE, et al: Mutations in ANAPC1, encoding a scaffold subunit of the anaphase-promoting complex, cause rothmund-thomson syndrome type 1. Am J Hum Genet. 105:625–630. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ping Z, Lim R, Bashir T, Pagano M and Guardavaccaro D: APC/C (Cdh1) controls the proteasome-mediated degradation of E2F3 during cell cycle exit. Cell Cycle. 11:1999–2005. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kernan J, Bonacci T and Emanuele MJ: Who guards the guardian? Mechanisms that restrain APC/C during the cell cycle. Biochim Biophys Acta Mol Cell Res. 1865:1924–1933. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wu Y, Xia L, Guo Q, Zhu J, Deng Y and Wu X: Identification of chemoresistance-associated key genes and pathways in high-grade serous ovarian cancer by bioinformatics analyses. Cancer Manag Res. 12:5213–5223. 2020. View Article : Google Scholar : PubMed/NCBI | |
Chen L, Zhang J, Li H, Niu J, Xue H, Liu B, Wang Q, Luo X, Zhang F, Zhao D and Cao S: Transcriptomic analysis reveals candidate genes for female sterility in pomegranate flowers. Front Plant Sci. 8:14302017. View Article : Google Scholar : PubMed/NCBI | |
Hou DL, Chen L, Liu B, Song LN and Fang T: Identification of common gene networks responsive to radiotherapy in human cancer cells. Cancer Gene Ther. 21:542–548. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lei Y, Henderson BR, Emmanuel C, Harnett PR and deFazio A: Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis. Oncogene. 34:485–495. 2015. View Article : Google Scholar : PubMed/NCBI | |
Takahashi A, Seike M, Chiba M, Takahashi S, Nakamichi S, Matsumoto M, Takeuchi S, Minegishi Y, Noro R, Kunugi S, et al: Ankyrin repeat domain 1 overexpression is associated with common resistance to afatinib and osimertinib in EGFR-mutant lung cancer. Sci Rep. 8:148962018. View Article : Google Scholar : PubMed/NCBI | |
Morone S, Lo-Buono N, Parrotta R, Giacomino A, Nacci G, Brusco A, Larionov A, Ostano P, Mello-Grand M, Chiorino G, et al: Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation. PLoS One. 7:e436492012. View Article : Google Scholar : PubMed/NCBI | |
Shim E, Shim H, Bae J, Lee H and Jeoung D: CAGE displays oncogenic potential and induces cytolytic T lymphocyte activity. Biotechnol Lett. 28:515–522. 2006. View Article : Google Scholar : PubMed/NCBI | |
Janecki DM, Sajek M, Smialek MJ, Kotecki M, Ginter-Matuszewska B, Kuczynska B, Spik A, Kolanowski T, Kitazawa R, Kurpisz M and Jaruzelska J: SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma. Oncotarget. 9:32466–32477. 2018. View Article : Google Scholar : PubMed/NCBI | |
Satyavarapu EM, Nath S and Mandal C: Desialylation of Atg5 by sialidase (Neu2) enhances autophagosome formation to induce anchorage-dependent cell death in ovarian cancer cells. Cell Death Discov. 7:262021. View Article : Google Scholar : PubMed/NCBI | |
Ehrenreich H, Hasselblatt M, Knerlich F, von Ahsen N, Jacob S, Sperling S, Woldt H, Vehmeyer K, Nave KA and Sirén AL: A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci USA. 102:862–867. 2005. View Article : Google Scholar : PubMed/NCBI | |
Puls KL, Ni J, Liu D, Morahan G and Wright MD: The molecular characterisation of a novel tetraspanin protein, TM4-B(1). Biochim Biophys Acta. 1447:93–99. 1999. View Article : Google Scholar : PubMed/NCBI | |
Lascorz J, Chen B, Hemminki K and Forsti A: Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies. PLoS One. 6:e188672011. View Article : Google Scholar : PubMed/NCBI | |
Chang IW, Liu KW, Ragunanan M, He HL, Shiue YL and Yu SC: SERPINB5 expression: Association with CCRT response and prognostic value in rectal cancer. Int J Med Sci. 15:376–84. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhang Y, Cao L, Nguyen D and Lu H: TP53 mutations in epithelial ovarian cancer. Transl Cancer Res. 5:650–663. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ren YA, Mullany LK, Liu Z, Herron AJ, Wong KK and Richards JS: Mutant p53 promotes epithelial ovarian cancer by regulating tumor differentiation, metastasis, and responsiveness to steroid hormones. Cancer Res. 76:2206–2218. 2016. View Article : Google Scholar : PubMed/NCBI | |
Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR: AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA. 89:9267–9271. 1992. View Article : Google Scholar : PubMed/NCBI | |
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK and Testa JR: AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 23:5853–5857. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ghoneum A and Said N: PI3K-AKT-mTOR and NFkappaB pathways in ovarian cancer: Implications for targeted therapeutics. Cancers (Basel). 11:9492019. View Article : Google Scholar : PubMed/NCBI | |
Masoumi Moghaddam S, Amini A, Morris DL and Pourgholami MH: Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev. 31:143–162. 2012. View Article : Google Scholar : PubMed/NCBI | |
Yin X, Wang X, Shen B, Jing Y, Li Q, Cai MC, Gu Z, Yang Q, Zhang Z, Liu J, et al: A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis. Sci Rep. 6:310792016. View Article : Google Scholar : PubMed/NCBI | |
Glaysher S, Bolton LM, Johnson P, Atkey N, Dyson M, Torrance C and Cree IA: Targeting EGFR and PI3K pathways in ovarian cancer. Br J Cancer. 109:1786–1794. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wilken JA, Badri T, Cross S, Raji R, Santin AD, Schwartz P, Branscum AJ, Baron AT, Sakhitab AI and Maihle NJ: EGFR/HER-targeted therapeutics in ovarian cancer. Future Med Chem. 4:447–469. 2012. View Article : Google Scholar : PubMed/NCBI | |
Han GH, Chay DB, Nam S, Cho H, Chung JY and Kim JH: Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer. BMC Cancer. 19:12022019. View Article : Google Scholar : PubMed/NCBI | |
Cai J, Xu L, Tang H, Yang Q, Yi X, Fang Y, Zhu Y and Wang Z: The role of the PTEN/PI3K/Akt pathway on prognosis in epithelial ovarian cancer: A meta-analysis. Oncologist. 19:528–335. 2014. View Article : Google Scholar : PubMed/NCBI | |
Duncan TJ, Al-Attar A, Rolland P, Scott IV, Deen S, Liu DT, Spendlove I and Durrant LG: Vascular endothelial growth factor expression in ovarian cancer: A model for targeted use of novel therapies? Clin Cancer Res. 14:3030–3035. 2008. View Article : Google Scholar : PubMed/NCBI | |
Hu Q, Hisamatsu T, Haemmerle M, Cho MS, Pradeep S, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Wong STC, Sood AK and Afshar-Kharghan V: Role of platelet-derived Tgfβ1 in the progression of ovarian cancer. Clin Cancer Res. 23:5611–5621. 2017. View Article : Google Scholar : PubMed/NCBI | |
Bruchim I and Werner H: Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opin Ther Targets. 17:307–320. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kahan Z, Arencibia JM, Csernus VJ, Groot K, Kineman RD, Robinson WR and Schally AV: Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J Clin Endocrinol Metab. 84:582–589. 1999. View Article : Google Scholar : PubMed/NCBI | |
Yokoyama T, Kohn EC, Brill E and Lee JM: Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 50:1064–1074. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wang H, Liu C, Cheng J, Liu J, Zhang L, He C, Shen WH, Jin H, Xu L and Zhang Y: Arabidopsis flower and embryo developmental genes are repressed in seedlings by different combinations of polycomb group proteins in association with distinct sets of cis-regulatory elements. PLoS Genet. 12:e10057712016. View Article : Google Scholar : PubMed/NCBI | |
Diaz-Ruiz R, Rigoulet M and Devin A: The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Biophys Acta. 1807:568–576. 2011. View Article : Google Scholar : PubMed/NCBI | |
Balsa E, Marco R, Perales-Clemente E, Szklarczyk R, Calvo E, Landazuri MO and Enríquez JA: NDUFA4 is a subunit of complex IV of the mammalian electron transport chain. Cell Metab. 16:378–386. 2012. View Article : Google Scholar : PubMed/NCBI | |
Guerrero-Castillo S, Baertling F, Kownatzki D, Wessels HJ, Arnold S, Brandt U and Nijtmans L: The assembly pathway of mitochondrial respiratory chain complex i. Cell Metab. 25:128–139. 2017. View Article : Google Scholar : PubMed/NCBI | |
Tang JX, Thompson K, Taylor RW and Olahova M: Mitochondrial OXPHOS Biogenesis: Co-regulation of protein synthesis, import, and assembly pathways. Int J Mol Sci. 21:38202020. View Article : Google Scholar : PubMed/NCBI | |
Deng M, Blondeau JJ, Schmidt D, Perner S, Muller SC and Ellinger J: Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling. Genom Data. 5:173–175. 2015. View Article : Google Scholar : PubMed/NCBI | |
Muller FE, Braun M, Syring I, Klumper N, Schmidt D, Perner S, Hauser S, Müller SC and Ellinger J: NDUFA4 expression in clear cell renal cell carcinoma is predictive for cancer-specific survival. Am J Cancer Res. 5:2816–2822. 2015.PubMed/NCBI | |
Lunetti P, Di Giacomo M, Vergara D, De Domenico S, Maffia M, Zara V, Capobianco L and Ferramosca A: Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes. FEBS J. 286:688–709. 2019. View Article : Google Scholar : PubMed/NCBI |